ArticlePharmacology research & perspectives2022

The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker.

Matthew J Lawrence et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.